Global Psychotherapeutic Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 93 pages | ID: G479C91D7CABEN
QYResearch

Abstracts

This report focuses on the global Psychotherapeutic Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psychotherapeutic Drugs development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Eli Lilly
• Johnson&Johnson
• Pfizer
• Bristol-Myers Squibb
• Allergan
• GlaxoSmithKline
• AstraZeneca
• Astellas Pharma

Market segment by Type, the product can be split into

• Antipsychotic Drugs
• Antidepressants
• Psychotherapeutic Combinations

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Psychotherapeutic Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Psychotherapeutic Drugs development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Psychotherapeutic Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psychotherapeutic Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Psychotherapeutic Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Antipsychotic Drugs
  1.4.3 Antidepressants
  1.4.4 Psychotherapeutic Combinations
1.5 Market by Application
  1.5.1 Global Psychotherapeutic Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Psychotherapeutic Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Psychotherapeutic Drugs Industry
    1.6.1.1 Psychotherapeutic Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Psychotherapeutic Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Psychotherapeutic Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Psychotherapeutic Drugs Market Perspective (2015-2026)
2.2 Psychotherapeutic Drugs Growth Trends by Regions
  2.2.1 Psychotherapeutic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Psychotherapeutic Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Psychotherapeutic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Psychotherapeutic Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Psychotherapeutic Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Psychotherapeutic Drugs Players by Market Size
  3.1.1 Global Top Psychotherapeutic Drugs Players by Revenue (2015-2020)
  3.1.2 Global Psychotherapeutic Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Psychotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psychotherapeutic Drugs Market Concentration Ratio
  3.2.1 Global Psychotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Psychotherapeutic Drugs Revenue in 2019
3.3 Psychotherapeutic Drugs Key Players Head office and Area Served
3.4 Key Players Psychotherapeutic Drugs Product Solution and Service
3.5 Date of Enter into Psychotherapeutic Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Psychotherapeutic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Psychotherapeutic Drugs Forecasted Market Size by Type (2021-2026)

5 PSYCHOTHERAPEUTIC DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Psychotherapeutic Drugs Market Size by Application (2015-2020)
5.2 Global Psychotherapeutic Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Psychotherapeutic Drugs Market Size (2015-2020)
6.2 Psychotherapeutic Drugs Key Players in North America (2019-2020)
6.3 North America Psychotherapeutic Drugs Market Size by Type (2015-2020)
6.4 North America Psychotherapeutic Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Psychotherapeutic Drugs Market Size (2015-2020)
7.2 Psychotherapeutic Drugs Key Players in Europe (2019-2020)
7.3 Europe Psychotherapeutic Drugs Market Size by Type (2015-2020)
7.4 Europe Psychotherapeutic Drugs Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Psychotherapeutic Drugs Market Size (2015-2020)
8.2 Psychotherapeutic Drugs Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Psychotherapeutic Drugs Market Size by Type (2015-2020)
8.4 Asia-Pacific Psychotherapeutic Drugs Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Eli Lilly
  9.1.1 Eli Lilly Company Details
  9.1.2 Eli Lilly Business Overview and Its Total Revenue
  9.1.3 Eli Lilly Psychotherapeutic Drugs Introduction
  9.1.4 Eli Lilly Revenue in Psychotherapeutic Drugs Business (2015-2020))
  9.1.5 Eli Lilly Recent Development
9.2 Johnson&Johnson
  9.2.1 Johnson&Johnson Company Details
  9.2.2 Johnson&Johnson Business Overview and Its Total Revenue
  9.2.3 Johnson&Johnson Psychotherapeutic Drugs Introduction
  9.2.4 Johnson&Johnson Revenue in Psychotherapeutic Drugs Business (2015-2020)
  9.2.5 Johnson&Johnson Recent Development
9.3 Pfizer
  9.3.1 Pfizer Company Details
  9.3.2 Pfizer Business Overview and Its Total Revenue
  9.3.3 Pfizer Psychotherapeutic Drugs Introduction
  9.3.4 Pfizer Revenue in Psychotherapeutic Drugs Business (2015-2020)
  9.3.5 Pfizer Recent Development
9.4 Bristol-Myers Squibb
  9.4.1 Bristol-Myers Squibb Company Details
  9.4.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  9.4.3 Bristol-Myers Squibb Psychotherapeutic Drugs Introduction
  9.4.4 Bristol-Myers Squibb Revenue in Psychotherapeutic Drugs Business (2015-2020)
  9.4.5 Bristol-Myers Squibb Recent Development
9.5 Allergan
  9.5.1 Allergan Company Details
  9.5.2 Allergan Business Overview and Its Total Revenue
  9.5.3 Allergan Psychotherapeutic Drugs Introduction
  9.5.4 Allergan Revenue in Psychotherapeutic Drugs Business (2015-2020)
  9.5.5 Allergan Recent Development
9.6 GlaxoSmithKline
  9.6.1 GlaxoSmithKline Company Details
  9.6.2 GlaxoSmithKline Business Overview and Its Total Revenue
  9.6.3 GlaxoSmithKline Psychotherapeutic Drugs Introduction
  9.6.4 GlaxoSmithKline Revenue in Psychotherapeutic Drugs Business (2015-2020)
  9.6.5 GlaxoSmithKline Recent Development
9.7 AstraZeneca
  9.7.1 AstraZeneca Company Details
  9.7.2 AstraZeneca Business Overview and Its Total Revenue
  9.7.3 AstraZeneca Psychotherapeutic Drugs Introduction
  9.7.4 AstraZeneca Revenue in Psychotherapeutic Drugs Business (2015-2020)
  9.7.5 AstraZeneca Recent Development
9.8 Astellas Pharma
  9.8.1 Astellas Pharma Company Details
  9.8.2 Astellas Pharma Business Overview and Its Total Revenue
  9.8.3 Astellas Pharma Psychotherapeutic Drugs Introduction
  9.8.4 Astellas Pharma Revenue in Psychotherapeutic Drugs Business (2015-2020)
  9.8.5 Astellas Pharma Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Psychotherapeutic Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Psychotherapeutic Drugs Revenue
Table 3. Ranking of Global Top Psychotherapeutic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Psychotherapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antipsychotic Drugs
Table 6. Key Players of Antidepressants
Table 7. Key Players of Psychotherapeutic Combinations
Table 8. COVID-19 Impact Global Market: (Four Psychotherapeutic Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Psychotherapeutic Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Psychotherapeutic Drugs Players to Combat Covid-19 Impact
Table 13. Global Psychotherapeutic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Psychotherapeutic Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Psychotherapeutic Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Psychotherapeutic Drugs Market Share by Regions (2015-2020)
Table 17. Global Psychotherapeutic Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Psychotherapeutic Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Psychotherapeutic Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Psychotherapeutic Drugs Players
Table 24. Global Psychotherapeutic Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Psychotherapeutic Drugs Market Share by Players (2015-2020)
Table 26. Global Top Psychotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotherapeutic Drugs as of 2019)
Table 27. Global Psychotherapeutic Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Psychotherapeutic Drugs Product Solution and Service
Table 30. Date of Enter into Psychotherapeutic Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Psychotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Psychotherapeutic Drugs Market Size Share by Type (2015-2020)
Table 34. Global Psychotherapeutic Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Psychotherapeutic Drugs Market Size Share by Application (2015-2020)
Table 36. Global Psychotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Psychotherapeutic Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Psychotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Psychotherapeutic Drugs Market Share (2019-2020)
Table 40. North America Psychotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Psychotherapeutic Drugs Market Share by Type (2015-2020)
Table 42. North America Psychotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Psychotherapeutic Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Psychotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Psychotherapeutic Drugs Market Share (2019-2020)
Table 46. Europe Psychotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Psychotherapeutic Drugs Market Share by Type (2015-2020)
Table 48. Europe Psychotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Psychotherapeutic Drugs Market Share by Application (2015-2020)
Table 50. Asia-Pacific Key Players Psychotherapeutic Drugs Revenue (2019-2020) (Million US$)
Table 51. Asia-Pacific Key Players Psychotherapeutic Drugs Market Share (2019-2020)
Table 52. Asia-Pacific Psychotherapeutic Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. Asia-Pacific Psychotherapeutic Drugs Market Share by Type (2015-2020)
Table 54. Asia-Pacific Psychotherapeutic Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. Asia-Pacific Psychotherapeutic Drugs Market Share by Application (2015-2020)
Table 56. Eli Lilly Company Details
Table 57. Eli Lilly Business Overview
Table 58. Eli Lilly Product
Table 59. Eli Lilly Revenue in Psychotherapeutic Drugs Business (2015-2020) (Million US$)
Table 60. Eli Lilly Recent Development
Table 61. Johnson&Johnson Company Details
Table 62. Johnson&Johnson Business Overview
Table 63. Johnson&Johnson Product
Table 64. Johnson&Johnson Revenue in Psychotherapeutic Drugs Business (2015-2020) (Million US$)
Table 65. Johnson&Johnson Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Product
Table 69. Pfizer Revenue in Psychotherapeutic Drugs Business (2015-2020) (Million US$)
Table 70. Pfizer Recent Development
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Product
Table 74. Bristol-Myers Squibb Revenue in Psychotherapeutic Drugs Business (2015-2020) (Million US$)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. Allergan Company Details
Table 77. Allergan Business Overview
Table 78. Allergan Product
Table 79. Allergan Revenue in Psychotherapeutic Drugs Business (2015-2020) (Million US$)
Table 80. Allergan Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Revenue in Psychotherapeutic Drugs Business (2015-2020) (Million US$)
Table 85. GlaxoSmithKline Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Product
Table 89. AstraZeneca Revenue in Psychotherapeutic Drugs Business (2015-2020) (Million US$)
Table 90. AstraZeneca Recent Development
Table 91. Astellas Pharma Business Overview
Table 92. Astellas Pharma Product
Table 93. Astellas Pharma Company Details
Table 94. Astellas Pharma Revenue in Psychotherapeutic Drugs Business (2015-2020) (Million US$)
Table 95. Astellas Pharma Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Psychotherapeutic Drugs Market Share by Type: 2020 VS 2026
Figure 2. Antipsychotic Drugs Features
Figure 3. Antidepressants Features
Figure 4. Psychotherapeutic Combinations Features
Figure 5. Global Psychotherapeutic Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Psychotherapeutic Drugs Report Years Considered
Figure 10. Global Psychotherapeutic Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Psychotherapeutic Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Psychotherapeutic Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Psychotherapeutic Drugs Market Share by Players in 2019
Figure 15. Global Top Psychotherapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotherapeutic Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Psychotherapeutic Drugs Revenue in 2019
Figure 17. North America Psychotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Psychotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Asia-Pacific Psychotherapeutic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. Eli Lilly Revenue Growth Rate in Psychotherapeutic Drugs Business (2015-2020)
Figure 22. Johnson&Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Johnson&Johnson Revenue Growth Rate in Psychotherapeutic Drugs Business (2015-2020)
Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Pfizer Revenue Growth Rate in Psychotherapeutic Drugs Business (2015-2020)
Figure 26. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bristol-Myers Squibb Revenue Growth Rate in Psychotherapeutic Drugs Business (2015-2020)
Figure 28. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Allergan Revenue Growth Rate in Psychotherapeutic Drugs Business (2015-2020)
Figure 30. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GlaxoSmithKline Revenue Growth Rate in Psychotherapeutic Drugs Business (2015-2020)
Figure 32. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AstraZeneca Revenue Growth Rate in Psychotherapeutic Drugs Business (2015-2020)
Figure 34. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Astellas Pharma Revenue Growth Rate in Psychotherapeutic Drugs Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed